Objectives: E. coli O25b-ST131 has disseminated worldwide in hospitals and the community. The objective of this study was to determine the extent to which E. coli O25b-ST131 accounts for extended-spectrum beta-lactamase (ESBL)-producing E. coli from clinical samples from all sources in this region.
INTRODUCTION
The E. coli O25b:ST131 clonal group was first reported in 2008 as a major carrier of CTX-M-15 however subsequent studies have identified the presence of this clonal group in earlier isolates dating back to 1967. 1 Since then it has been reported globally in both the hospital and community setting and is associated primarily with urinary tract infections and bacteraemia. Reported risk factors for E. coli O25b-ST131 include foreign travel, antimicrobial usage, catheterisation and admission to a nursing home.
2-4
E. coli O25b-ST131 are often resistant to fluoroquinolones and cephalosporins such as ceftazidime. 1 The dissemination of bla is closely associated with E. coli O25b-ST131 however bla , bla and bla have also been observed. In addition, a broad range of other antimicrobial resistance genes (bla OXA-1 , bla TEM , tetA, aac (6' )-Ib-cr and aac(3)-II) primarily carried on transferable IncF plasmids are also associated with the group. 5 An increasing population of older people resides in nursing homes for extended periods. Nursing homes are associated with a significant number of antimicrobial-resistant (AMR) bacteria related to frequent transfer of patients from hospitals and also to factors within the nursing homes including the vulnerability of residents, and antimicrobial consumption. 6 The relative importance of acquisition of AMR bacteria during hospital stay compared with dissemination within nursing homes is not well understood. We have examined the diversity of extended-spectrum beta-lactamase (ESBL)-producing E. coli isolates from all clinical samples submitted to one laboratory over 6 consecutive months to compare isolates from nursing home residents with other isolates. All E. coli isolates are tested for susceptibility to cefpodoxime (Oxoid Ltd, UK) and cefpodoxime non-susceptible isolates were initially assessed for ESBL production using cefpodoxime/clavulanic acid discs in accordance with Clinical Laboratory Science Institute (CLSI) methods and criteria. Ninety four ESBL-producing E. coli were collected from urine (n=80), blood (n=3), sputum (n=9), drainage fluid (n=1), and tissue (n=1).
METHODS

Galway
Forty seven ESBL-producing E. coli isolates were from residents of 25 nursing homes (21 private and 4 public; NH=47), and 47 were non-nursing home isolates. Of the 25 nursing homes, 18 were represented by a single isolate, 2 by 2 isolates and the remaining five nursing homes by 3 or more isolates. The number of beds in each nursing home varied from 28 to 62. The nursing home samples were submitted in the course of routine investigation of clinical episodes of suspected infection and the interval between admission to the nursing home and date of sample collection was not available. Fifteen ESBL-producing E. coli were categorized as likely hospital associated (HA) on the basis that the clinical samples were collected more than 48 hours after admission (range 3-79 days). Of the remaining 32 isolates of ESBL-producing E. coli, 4 were from General Practitioners and 28 were from hospitalized patients but with samples collected (a) at or within 48 hours of admission (n= 16) or (b) submitted from a hospital but with interval from admission to sampling not accessible (n=12). For purposes of this study these 32 isolates are classified as "others". Thirty of the 32 "others" had previous hospital contact (out-patient and in-patient). There was no record of nursing home admission for those patients hospitalized at time of sampling.
The E. coli ST131 clonal group was identified by PCR specific to the detection of the pabB gene (specific marker the E. coli O25b-ST131 clonal group) and the trpA gene (to act as a control and to ensure quality of DNA). 7 All ESBL isolates were also tested for bla TEM , bla SHV , bla OXA-1 and bla CTX-M as previously described and representative bla genes were sequenced using primers specific to the entire coding region of bla CTX-M-group 1 , bla TEM and bla SHV (Sequiserve, Vaterstetten, Germany). 8, 9 Pulsed field gel electrophoresis (PFGE) using XbaI was performed by the Pulse-Net protocol with analysis of profiles (PFPs) using the Dice coefficient with clustering by the unweighted pair group method with arithmetic averaging (UPGMA). 10 Three major UK ST131 . One NH E. coli harbored bla SHV-2 , bla CTX-M-group 1 , bla OXA-1 and bla TEM . A higher percentage of nursing home isolates were ST131 (96%) compared with hospitals associated (87%) and "other" ESBL-producing E. coli (75%) although the differences did not reach statistical significance (Table 1) . Among the 12 non-ST131 bla CTX-M was also predominant (n=10) with the remaining isolates being bla SHV-2 (n=1) in one case and both bla and bla TEM in the other. PFGE analysis identified 65 pulsed field profiles (PFPs) within the 94 isolates and the reference Strain A. PFP's of the E. coli ST131 were > 78% similar. The ST131 isolates formed 3 clusters X to Z, based on a similarity of > 85%. Cluster X included the pandemic UK Strain A and 45 local isolates (NH n=19; OT=17; HA n=9; UK Strain A control n=1). Cluster Y comprised mainly nursing home isolates (NH n=9, HP n=3; OT=1). Most cluster Z isolates (NH n=10; OT=2; HP n=1) were from nursing homes and in particular one nursing home provided 7 (54%) of all cluster Z isolates ( Table 2) .
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The two non-ST131 nursing home isolates were from residents of the same nursing home and were indistinguishable by PFGE, and one of these was confirmed by sequencing to harbor bla CTX-M-61 . The 10 non-ST131 isolates from 2 hospital patients and 8 from the OT category were all quite distinct (61% similar) on PFGE and were 58% similar to the group of ST131 isolates.
DISCUSSION
The association of AMR with nursing homes is well described however the relative importance of dissemination within nursing homes compared with acquisition during episodes of care for nursing home residents at acute hospitals is not well understood. Rooney et al (2009) reported that CTX-M -producing E. coli O25b-ST131 accounted for 49% of ES-BL-producing E. coli from nursing homes in Northern Ireland. 3 Burke et al. (2012) reported E. coli O25b-ST131 represented 85% and 51% respectively of nursing home and hospital inpatient ESBLproducing E. coli isolated from Dublin, Ireland.
6 E. coli O25b-ST131 was reported to account for 21%, 43% and 41% of ESBL-producing E. coli isolates from Japan, South Africa and Canada, respectively. 4 In addition, E. coli O25b-ST131 was identified in 27% of isolates in the United States; however E. coli O25b-ST131 was detected in 76% of isolates from long-term care facilities in this region of the United States.
2 Our data confirm other reports of global dissemination of bla CTX-M-15 carrying E. coli O25b-ST131. Our study also demonstrates the striking predominance of this clonal group in this region of Ireland. Even by comparison with Burke and colleagues the predominance we observe (87% of all ESBL-producing E. coli) in this collection of consecutive clinical isolates from all sources is exceptionally high. In 2012 ESBL-producing E. coli accounted for 8.8% of all E. coli blood stream infections in Ireland as a whole. In comparison, ESBL-producing E. coli accounted for approximately 21.5% of E. coli (20-23%) blood stream infections for most hospitals in the West of Ireland where this study was performed (S. Murchan, Health Protection Surveillance Centre, personal communication, January 8, 2013) . It is possible that there are differences between regions of Ireland with respect to case ascertainment related to differences indications for performing blood cultures and or in laboratory protocols for processing blood cultures and susceptibility testing. However we are aware of no systematic regional bias with respect to any of these factors therefore the differences are not readily explained as ascertainment bias. There are also some differences in population profile (higher mean age in the region with higher proportion of ESBL-producing E. coli) though it is not clear that this is sufficient to explain the difference.
11 It is interesting to speculate if the prevalence of a virulent clonal group in this region may contribute to the high incidence of ESBL-producing E. coli blood stream infection.
In conclusion this study demonstrates that a single clonal group, E. coli O25b-ST131 accounts for the vast majority of ESBL-producing E. coli in the West of Ireland, with a particular predominance (96%) in nursing home isolates. The ST131 variant designated as UK strain A represents almost half of all ESBL-producing E. coli from all sources. A unique aspect of this study is the comparison of the homogeneity of ESBL-producing E. coli in consecutive isolates from nursing home and other settings in the same region during a defined time period. Although this study is not sufficient to form firm conclusions we suggest that there is a trend towards greater homogeneity of ESBL-producing E. coli within the nursing home isolates. Given the growing nursing home population in developed countries and the practical challenges of implementing effective measures to control dissemination of AMR bacteria in nursing homes more comprehensive studies comparing nursing home isolates with non-nursing home isolates are required.
